2nd International Conference and Exhibition on Pathology, will be organized around the theme "To Stimulate the Technology in Pathology for Scientific Excellence"
2nd International Conference and Exhibition on Pathology, will be organized around the theme "To Stimulate the Technology in Pathology for Scientific Excellence"
IFPMA Geneva Pharma Forum on 9 May 2014
Bringing Psoriasis into the Light
Presentation of Kim kjoeller, Senior Vice President
Global Development, Leo Pharma
Discrimination and stéréotypes of medical information - أحكام مسبقة و نقص في ...Khadija Moussayer
بمناسبة اليوم العالمي للمرأة ،الذي يصادف 8 مارس من كل سنة ، تحذر الجمعية المغربية لأمراض المناعة الذاتية ، برئاسة الدكتورة خديجة موسيار ، من أوجه القصور والصور النمطية في المعلومات والحملات.التوعوية الطبية الموجهة للمرأة. هذا الأمر له عواقب سلبية على صحتهم. هناك مثالين يبينان قلة حملات التوعية بوضوح.
أمراض المناعة الذاتية، مشكل متجاهل في حين أنها تؤثر على واحدة من كل ست نساء
أمراض المناعة الذاتية جد متعددة يصل عددها إلى المائة و تصيب النساء في 75 ٪ من الحالات! تتجلى هذه الأمراض في خلل في الجهاز المناعي ،نفس جهاز المناعة الذي يكون على عاتقه حماية الجسم من العدوان الخارجي (الفيروسات والبكتيريا ...) ، هدا الجهاز ينقلب على الجسم و يبدأ في مهاجمة مكونات الجسم السليمة ضانا أنها عدو خارجي - بالإضافة إلى ذالك غالبًا ما تستجيب هذه الأمراض إلى نفس الاستراتيجيات العلاجية. وتشمل هذه الفئة: مرض جريفز (فرط الدرقية) ، التهاب الغدة الدرقية المزمن مرض هاشيموتو الذي يؤدي إلى قصور الغدة الدرقية، مرض الذئبة الحمراء، الوهن العضلي الوبيل ، التصلب المتعدد ، داء السكري من النوع 1 ، التهاب المفاصل الروماتويدي ، مرض السيلياك (عدم تحمل الغلوتين) ، مرض كرون ، متلازمة شوغرين...وعديد من أمراض مناعية ذاتية نادرة. . تشير التقديرات إلى أن عدد النساء المصابات بأمراض المناعة الذاتية يصل إلى ضعف عدد النساء اللواتي يعانون من سرطان الثدي ونحو مرة ونصف مرة أكثر من تلك المصابات بمرض الشريان التاجي!
International Women's Day, March 8, 2019, is an opportunity to warn about inequalities, discrimination and stereotypes that continue to affect women in medical information and awareness campaigns related to it . These gaps concern major issues of public health and have a significant impact on the health of women, particularly in intermediate countries such as Morocco.
This is the subject of autoimmune diseases: these many pathologies ̵; a hundred – concern women in 75% of cases ! In addition, the third leading cause of morbidity in the world after cardiovascular diseases and cancers, they affect about 10% of the world population and occupy the second or third position of the health budget in developed countries. In total, it is estimated that the number of women with autoimmune diseases is twice as high as that of women with breast cancer and almost one and a half times higher than those affected by coronary heart disease!
IFPMA Geneva Pharma Forum on 9 May 2014
Bringing Psoriasis into the Light
Presentation of Kim kjoeller, Senior Vice President
Global Development, Leo Pharma
Discrimination and stéréotypes of medical information - أحكام مسبقة و نقص في ...Khadija Moussayer
بمناسبة اليوم العالمي للمرأة ،الذي يصادف 8 مارس من كل سنة ، تحذر الجمعية المغربية لأمراض المناعة الذاتية ، برئاسة الدكتورة خديجة موسيار ، من أوجه القصور والصور النمطية في المعلومات والحملات.التوعوية الطبية الموجهة للمرأة. هذا الأمر له عواقب سلبية على صحتهم. هناك مثالين يبينان قلة حملات التوعية بوضوح.
أمراض المناعة الذاتية، مشكل متجاهل في حين أنها تؤثر على واحدة من كل ست نساء
أمراض المناعة الذاتية جد متعددة يصل عددها إلى المائة و تصيب النساء في 75 ٪ من الحالات! تتجلى هذه الأمراض في خلل في الجهاز المناعي ،نفس جهاز المناعة الذي يكون على عاتقه حماية الجسم من العدوان الخارجي (الفيروسات والبكتيريا ...) ، هدا الجهاز ينقلب على الجسم و يبدأ في مهاجمة مكونات الجسم السليمة ضانا أنها عدو خارجي - بالإضافة إلى ذالك غالبًا ما تستجيب هذه الأمراض إلى نفس الاستراتيجيات العلاجية. وتشمل هذه الفئة: مرض جريفز (فرط الدرقية) ، التهاب الغدة الدرقية المزمن مرض هاشيموتو الذي يؤدي إلى قصور الغدة الدرقية، مرض الذئبة الحمراء، الوهن العضلي الوبيل ، التصلب المتعدد ، داء السكري من النوع 1 ، التهاب المفاصل الروماتويدي ، مرض السيلياك (عدم تحمل الغلوتين) ، مرض كرون ، متلازمة شوغرين...وعديد من أمراض مناعية ذاتية نادرة. . تشير التقديرات إلى أن عدد النساء المصابات بأمراض المناعة الذاتية يصل إلى ضعف عدد النساء اللواتي يعانون من سرطان الثدي ونحو مرة ونصف مرة أكثر من تلك المصابات بمرض الشريان التاجي!
International Women's Day, March 8, 2019, is an opportunity to warn about inequalities, discrimination and stereotypes that continue to affect women in medical information and awareness campaigns related to it . These gaps concern major issues of public health and have a significant impact on the health of women, particularly in intermediate countries such as Morocco.
This is the subject of autoimmune diseases: these many pathologies ̵; a hundred – concern women in 75% of cases ! In addition, the third leading cause of morbidity in the world after cardiovascular diseases and cancers, they affect about 10% of the world population and occupy the second or third position of the health budget in developed countries. In total, it is estimated that the number of women with autoimmune diseases is twice as high as that of women with breast cancer and almost one and a half times higher than those affected by coronary heart disease!
Say no to cervical cancer-PUBLIC Awareness-Life Care Centre_Dr.Sharda JainLifecare Centre
Cervical Cancer in INDIA
Say no to cervical cancer
Dr.Sharda Jain
Life Care Centre
PUBLIC Awareness_Dr.Sharda Jain
HPV Infection
HPV Vaccination
Cervical Screening
SEE & TREAT Programme tp Prevent Cervical Cancer
WCRF International Continuous Update Project (CUP). Presentation given by Giota Mitrou PhD MSc, Head of Research Funding and Science Activities, World Cancer Research Fund International (WCRF International).
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Senology Newsletter - July 10, 2014
1. Senology.org - Newsletter
International Senologic and Oncologic Scientific Community (ISOSC)
"Connecting specialistsworldwide"
July 10,2014
Editor-in-Chief: Gian Paolo Andreoletti,MD
Senology apps for iPad, iPhone, and Android tabletsnowavailable, to provide anytime, anywhere accessto Senology contents
Join uson LinkedIn, Twitter, Facebook, YouTube, ResearchGate, SlideShare, Flickr, and share comments.
Read Senology Newspaper daily
Senology collaborates with
Literature Selection
LiuYet al.:"Adolescent dietaryfiber, vegetable fat, vegetable protein, andnut intakes andbreast
cancer risk", Breast Cancer Res Treat. 2014 Jun;145(2):461-70
Fraser DMet al.:"Aspirinuse andsurvival after the diagnosis of breast cancer:a population-based
cohort study", Br J Cancer. 2014 Jun19. doi:10.1038/bjc.2014.264. [Epubaheadof print]
TioMet al.:"Folate intake andthe risk of breast cancer:a systematic review andmeta-analysis",
Breast Cancer Res Treat. 2014 Jun;145(2):513-24
Fournier Aet al.:"Risk of breast cancer after stoppingmenopausal hormone therapyinthe E3N
cohort", Breast Cancer Res Treat. 2014 Jun;145(2):535-43
Ekenga CCet al.:"Breast cancer risk after occupational solvent exposure:the influence of timingand
setting", Cancer Res. 2014 Jun1;74(11):3076-83
TsengCHet al. "Metformin mayreduce breast cancer risk inTaiwanese womenwithtype 2 diabetes",
Breast Cancer Res Treat. 2014 Jun;145(3):785-90
Weedon-Fekiaer Het al.:"Modernmammographyscreeningandbreast cancer mortality:population
study", 14 Jun17;348:g3701. doi:10.1136/bmj.g3701
Chiarelli AMet al.:"Effectiveness of ScreeningWithAnnual Magnetic Resonance Imagingand
Mammography:Results of the Initial ScreenFromthe OntarioHighRisk Breast ScreeningProgram", J
ClinOncol. 2014 Jun16. pii:JCO.2013.52.8331. [Epubaheadof print]
SungJSet al.:"Preoperative breast MRI for early-stage breast cancer:effect onsurgical andlong-term
outcomes", AJRAmJ Roentgenol. 2014 Jun;202(6):1376-82
RushtonMet al.:"Treatment outcomes for male breast cancer:a single-centre retrospective case-
control study", Curr Oncol. 2014 Jun;21(3):e400-7. doi:10.3747/co.21.1730
Castellar JI et al.:"Beneficial Effects of Pranic Meditationonthe Mental HealthandQualityof Life of
Breast Cancer Survivors", Integr Cancer Ther. 2014 Jun5. pii:1534735414534730. [Epubaheadof
print]
Editorial
"Increasedrisk of developingbreast cancer fromhighsaturatedfat intake" - Sabina Sieri, Unità
Operativa di Epidemiologia, Istituto Nazionale dei Tumori di Milano, Milan, italy
Calendar of Events
10thMeet the Professor. AdvancedInternational Breast Cancer Conference (AIBCC), November 6-8
2014, Padua, Italy- under the Patronage of Senology
2ndBreast Cancer inYoungWomenConference (BCY2), 6-7 November 2014, Tel Aviv, Israel
Late andlater relapses andsequelae:the dilemma of endocrine treatment duration, compliance and
treatment tailoring, November 7 2014, Milan, Italy
converted by Web2PDFConvert.com
2. Literature Selection
SchmidDet al.:"TelevisionViewingandTime Spent SedentaryinRelationtoCancer Risk:AMeta-
analysis", J Natl Cancer Inst. 2014 Jun16;106(7). pii:dju098
Streicher SAet al.:"Case-Control Studyof AspirinUse andRisk of Pancreatic Cancer, Cancer
Epidemiol Biomarkers Prev. 2014 Jun26. [Epubaheadof print]
Sekikawa Aet al.;"Diabetes mellitus increases the risk of earlygastric cancer development", Eur J
Cancer. 2014 Jun13 [Epubaheadof print]
KimCet al.:"Home kitchenventilation, cookingfuels, andlungcancer risk ina prospective cohort of
never smokingwomeninShanghai, China", Int J Cancer. 2014 Jun11. doi:10.1002/ijc.29020. [Epub
aheadof print]
Zoller Bet al.:"Familial transmissionof prostate, breast andcolorectal cancer inadoptees is relatedto
cancer inbiological but not inadoptive parents:Anationwide familystudy", Eur J Cancer. 2014 Jun18.
pii:S0959-8049(14)00717-5. doi:10.1016/j.ejca.2014.05.018. [Epubaheadof print]
Literature Selection
GibranLet al.:"Couldstatins constitute a novel treatment for endometriosis?Systematic review of the
literature", Eur J Obstet Gynecol ReprodBiol. 2014 Jun2;179C:153-158
Li CLet al.:"Use of menopausal hormone therapyandrisk of ductal andlobular breast cancer among
women55-74 years of age", Breast Cancer Res Treat. 2014 Jun;145(2):481-9
Subscribe Unsubscribe Contact Back Issues
Senology.it Newsletter
www.senology.org
converted by Web2PDFConvert.com